Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tight-lipped Merck KGaA to remedy 'inefficiency' before investing in growth

This article was originally published in Scrip

Executive Summary

There was disappointment today for those who were hoping that during its annual results conference Merck KGaA would provide further details of the "efficiency measures" announced last month. The company remained tight-lipped about the two-year restructuring programme, which will involve yet to be defined "workforce reductions across all divisions and geographies" (scripintelligence.com, 24 February 2012). The company said it would not go into detail about these measures until it announced its first-quarter results on 15 May.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC016516

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel